Full Text View
Tabular View
No Study Results Posted
Related Studies
The Treatment of Depression With Botulinum Type A Toxin
This study is currently recruiting participants.
Verified April 2013 by Seton Family of Hospitals
Study NCT01392963   Information provided by Seton Family of Hospitals

First Received on July 8, 2011.   Last Updated on April 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depression
Additional conditions recognized in this trial
Depressive Disorder
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
0.9% NaCl solution
Additional drug interventions recognized in this trial
Botulinum Toxins
Botulinum Toxins, Type A
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Central Nervous System Agents
Neuromuscular Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Seton Family of Hospitals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services